Abbeha Talib: Balancing Stroke Prevention and Bleeding Risk After Successful AF Ablation
Abbeha Talib, Social Media Manager and Content Strategist at Medify HELP, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Cardiology in Review, adding:
“Excited to share that our latest work has been published in Cardiology in Review:
‘Discontinuation of Oral Anticoagulants After Successful Atrial Fibrillation Ablation: A Systematic Review and Meta-Analysis.’
What we explored:
In this large-scale analysis, we examined whether oral anticoagulation (OAC) can be safely discontinued after successful catheter ablation for atrial fibrillation (AF), comparing long-term outcomes of OAC discontinuation (OFF-OAC) versus continuation (ON-OAC).
Key findings: (29 studies, 153,352 participants):
- No significant difference in thromboembolic risk with OAC discontinuation (OR: 0.91; P = 0.60)
- OFF-OAC significantly reduced major bleeding risk by approximately 66 percent (OR: 0.34; P less than 0.00001)
- No significant difference in all-cause mortality (OR: 0.67; P = 0.06)
- OAC discontinuation was associated with significantly lower AF recurrence (OR: 0.57; P = 0.0003)
Subgroup insights:
- Greater bleeding reduction with OAC discontinuation was observed in:
- Warfarin users (OR: 0.13) versus warfarin/NOAC users (OR: 0.43)
- Non-Asian cohorts (OR: 0.12) versus Asian cohorts (OR: 0.45)
- Patients switched to antiplatelet therapy (OR: 0.18) versus those not switched (OR: 0.44)
Takeaway:
Discontinuing OAC after successful AF ablation significantly reduces major bleeding without increasing thromboembolic or mortality risk in appropriately selected patients.
OAC may be safely withdrawn in low-risk patients (CHA₂DS₂-VASc less than 2) with careful monitoring, while high-risk patients warrant individualized decision-making.
Grateful to my coauthors Muhammad Tahir, Muhammad Abdullah Naveed, Muhammad Hamza Khan, Muhammad Shaheer Hussain Qureshi, Susheeta Rani, Abdur Rafay Bilal, Muhammad Salik Khan, Shaheer Bin Shafiq, Ali A. Mithani, Saad Ahmed Waqas and mentors for their collaboration on this project.”
Title: Discontinuation of Oral Anticoagulants After Successful Atrial Fibrillation Ablation: A Systematic Review and Meta-Analysis
Authors: Tahir Muhammad, Naveed Muhammad Abdullah, Khan Muhammad Hamza, Qureshi Shaheer, Rani Susheeta, Bilal Abdur Rafay, Talib Abbeha, Uddin Muhammad Salik, Bin Shafiq Shaheer, Mithani, Ali A., Waqas Saad Ahmed
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 23, 2026, 13:44How Sickle Hemoglobin Fuels Thrombosis and Vascular Injury – JTH
-
Jun 23, 2026, 13:30Amit Malhotra: The Expanding Role of Upadacitinib Across Autoimmune and Inflammatory Disorders
-
Jun 23, 2026, 13:10Scott Cameron: Olfactory Receptor Signaling as a Druggable Target in Cardiovascular Disease
-
Jun 23, 2026, 12:52Zain Khalpey: Understanding the Mechanisms of Sudden Cardiac Death
-
Jun 23, 2026, 12:43Victoria Azodoh: Strengthening Maternal Nutrition Through Evidence-Based Action
-
Jun 23, 2026, 12:37Sophia Delicou: Featured on the Cover of the British Journal of Haematology
-
Jun 23, 2026, 12:29Mattia Liverani։ AHA Highlights New Approaches in Iron Deficiency Management
-
Jun 23, 2026, 12:19Maha Sallam: What Baseline Hemoglobin Reveals About SCA
-
Jun 23, 2026, 11:05Vicky Williams: The Impact of the Stroke Same Day Emergency Care Model on The Outcomes